Webinar from Accelagen and Griffith University Highlighting a Groundbreaking Clinical Trial for Spinal Cord Injury using Cell-Based Therapy
The Australian medical research community continues to push the boundaries of innovation, rapidly translating cutting-edge therapies from the lab to patients with the support of a well-established clinical trials sector. In this exclusive webinar, Accelagen will describe what it takes to progress new medical therapies to the clinic in Australia, introducing its partners from Griffith University who are leading a groundbreaking clinical trial for spinal cord injury treatment as a case study.
In this webinar, Accelagen discusses how a novel cell therapy technology is advancing with the support of Australia’s world-class regulatory framework and research infrastructure. Discover how Accelagen, a leading Australian CRO, is playing a crucial role in guiding and accelerating this transformative therapy from discovery to human trials—offering new hope for patients worldwide. Gain insights into a potential game-changer in spinal cord injury treatment and to understand the experience and leadership required to take the innovative approach into trials.
Spinal cord injuries have long been among the most challenging medical conditions to treat, often resulting in permanent disability. This Phase I clinical trial developed by Griffith University's Clem Jones Centre explores the use of olfactory ensheathing cells (OECs)—specialised cells from the nose known for their nerve repair properties – to stimulate repair and bring hope of recovery to patients. By harvesting and reintroducing these cells into the injury site, researchers aim to bridge damaged nerve tissues, stimulate regeneration, and restore lost functions, such as mobility and sensation.
1.) Exclusive Insights from Leading Experts
- Learn directly from Professor James St John, the lead researcher at Griffith University, about the years of discovery research leading to this trial.
- Hear from Accelagen’s clinical trial specialists on the unique challenges and strategies involved in bringing this novel therapy to patients.
2.) Understanding the Clinical Trial Process
- Gain an overview of how this innovative study is being conducted.
- Learn about the regulatory, ethical, and logistical considerations in running a world-first cell therapy trial and the advantages of running trials in Australia.
3.) The Future of SCI Treatment
- Explore how this research could revolutionise not just SCI treatment, but also other neurodegenerative conditions.
- Find out what’s next in the journey toward making this therapy widely available.
.png)
